Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users—A National Survey Study
Bibliographic Data
| ID | 15718255 |
|---|---|
| Authors | Saral Desai (0000-0003-4692-1414, Phoenixville Hospital, corresponding author), Vidisha Jain (Jawaharlal Nehru Medical College), Sona Xavier (Father Muller Medical College Hospital), Wei Du (0000-0001-5941-2382, Reading Hospital) |
| Year | 2022 |
| Volume | 9 |
| Issue | 12 |
| Pages | 1906-1906 |
| Publication date | 2022-12-05 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Children (JOURNAL) |
| Journal identifiers | ISSN: 2227-9067 • E-ISSN: 2227-9067 |
| Publisher | Multidisciplinary Digital Publishing Institute (PUBLISHER • CH) |
| DOI | 10.3390/children9121906 |
| PMID | 36553349 |
| OpenAlex | W4311627573 |
| Language | EN |
| Citations received | 1 |
| References cited | 42 |
(1) Objectives: Hallucinogens are being explored as a potential treatment of psychiatric disorders. Micro dosing of illicitly purchased hallucinogen drugs is on the rise despite conclusive benefits. We aimed to evaluate the prevalence and odds of hopelessness, suicidality, and co-occurring substance use among adolescent hallucinogen users. (2) Methods: We performed a retrospective analysis of the Centers for Disease Control and Prevention’s Youth Risk Behavior Surveillance System (YRBSS) 2001−2019 data that nationally represents school-going US adolescents. We identified hallucinogen use based on the survey questions, exploring the use of hallucinogens (LSD, PCP, mescaline, and mushrooms). (3) Results: Out of a total of 125,550 respondents, 8.4% reported using hallucinogens. Overall, the trend of hallucinogen use decreased from 13.3% (2001) to 7.0% (2019) (pTrend < 0.0001). Hallucinogen users were at high odds of feeling sad and hopeless (aOR: 1.40; 95%CI: 1.21−1.61; p < 0.0001), considering suicide (aOR: 1.36; 95%CI: 1.08−1.70; p = 0.009), and planning suicide (aOR: 1.49; 95%CI: 1.19−1.86; p = 0.001). Additionally, adolescent hallucinogen users had a higher prevalence of alcohol, cigarette, e-cigarette, marijuana, synthetic marijuana, inhalants, heroin, cocaine, methamphetamine, and ecstasy use. (4) Conclusions: The overall trend of hallucinogen use decreased among school-going American adolescents. We found a high prevalence of co-occurring substance use among hallucinogen users. We found that hallucinogen users were at high odds of feeling sad, hopeless, and considering and planning suicide. Further research is needed to explore the effects of recreational hallucinogen use among the adolescent population
Ecstasy · Environmental health · Feeling · Hallucinogen · MDMA · Mescaline · Poison control · Psychiatry · Cannabis and Cannabinoid Research · Medicine · Psychedelics and Drug Studies · Psychology · Tryptophan and brain disorders
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer
Survey study of challenging experiences after ingesting psilocybin mushrooms
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Impulsivity as a vulnerability marker for substance-use disorders
Classic psychedelics
Psychedelics not linked to mental health problems or suicidal behavior
Human hallucinogen research
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Gender Differences in Substance Use Disorders
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
Hallucinogens
Psilocybin with psychological support for treatment-resistant depression
Psychedelics
Substance Abuse in Women
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Psilocybin-assisted treatment for alcohol dependence
Linking "big" personality traits to anxiety, depressive, and substance use disorders
| Citations per year | 1 |
|---|---|
| Citation span | 2025 - 2025 (1) |
| Highly cited | No |